Biotech · Private company
Arthritis Innovation Corporation
Track this companyFree. Adds Arthritis Innovation Corporation to your Dealase workspace and tells you when its record changes.
Clinical trials30 recruiting or active
Pipeline programs7From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline7
- 0.25 % Bupivacaine HClPhase 3 · Post Operative PainClinicalTrials.gov · fetched Nov 12, 2026
- AcetaminophenPhase 3 · Post Operative PainClinicalTrials.gov · fetched Nov 12, 2026
- F14Phase 3 · Post Operative PainClinicalTrials.gov · fetched Nov 12, 2026
- F14 (sustained release celecoxib)Phase 3 · AnalgesiaClinicalTrials.gov · fetched Nov 12, 2026
- MethocarbamolPhase 3 · Post Operative PainClinicalTrials.gov · fetched Nov 12, 2026
- Bupivacaine HClPhase 2 · Total Knee ReplacementClinicalTrials.gov · fetched Nov 12, 2026
- F14 (celecoxib)Phase 2 · Total Knee ReplacementClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials3
- Safety of F14 Following Total Knee ReplacementPHASE2_PHASE3 · SUSPENDED · started Jan 1, 2027ClinicalTrials.gov NCT04860635 · fetched Nov 12, 2026
- A Phase 3 Study of F14 for Management of Pain Following Total Knee ReplacementPHASE3 · COMPLETED · started Nov 17, 2022ClinicalTrials.gov NCT05603832 · fetched Nov 12, 2026
- Safety and Activity of F14 for Management of Pain Following Total Knee ReplacementPHASE2 · COMPLETED · started May 4, 2018ClinicalTrials.gov NCT03541655 · fetched Nov 12, 2026